Clinical Trials Logo
  1. Home
  2. Post-Menopausal Osteoporosis
  3. NCT00533650
  4. Details
NCT00533650 Clinical Trial

Proof of Concept (Bone Resorption/Bone Mineral Density) Study (0429-005)

Post-Menopausal Osteoporosis Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT00533650
Other study ID # 0429-005
Secondary ID 2007_620
Status Completed
Phase Phase 2
First received September 19, 2007
Last updated July 28, 2016
Start date December 2000
Est. completion date October 2002

Study information
Verified date May 2016
Source Merck Sharp & Dohme Corp.
Contact n/a
Is FDA regulated No
Health authority United States: Food and Drug Administration
Study type Interventional

Clinical Trial Summary

A study to asses the safety and efficacy of MK0429 in postmenopausal women with osteoporosis.

Recruitment information / eligibility
Status Completed
Enrollment 227
Est. completion date October 2002
Est. primary completion date October 2002
Accepts healthy volunteers No
Gender Female
Age group 50 Years to 75 Years
Eligibility Inclusion Criteria:

- Person is a women with osteoporosis who is unwilling or unable to take other treatments for osteoporosis

Exclusion Criteria:

- Person has had a previous fracture

- Person has rheumatoid arthritis. Person has has certain types of cancer

- Person has donated blood or has been in another investigational study within the last 4 weeks

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment

Related Conditions & MeSH terms

Intervention

Drug:
• MK0429

Locations
Country Name City State
n/a

Sponsors (1)
Lead Sponsor Collaborator
Merck Sharp & Dohme Corp.
See also
  Status Clinical Trial Phase
Completed NCT01224717 - Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Doses of PTH134 in Post-menopausal Women Phase 1
Completed NCT00551174 - A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Who Have Received Previous Bonviva Treatment Phase 4
Completed NCT00984893 - Intra-venous Zoledronic Acid Once Yearly N/A
Withdrawn NCT01826656 - Bone Healing in Healthy and Post-menopausal Osteoporotic Women N/A
Completed NCT00718861 - 3 yr Efficacy & Safety Study of Zoledronic Acid in Post-menopausal Women With Osteoporosis Treated With Zol Acid for 6 Yrs Phase 3
Completed NCT00081653 - A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Previously Treated With Bonviva Phase 4
Completed NCT00503113 - A Study of Bonviva (Ibandronate) and Alendronate on Renal Function in Postmenopausal Women With Osteoporosis at High Risk for Renal Disease. Phase 4
Completed NCT00150969 - Vitamin K Supplementation in Post-Menopausal Osteopenia Phase 3
Completed NCT03432533 - A Comparison of Subject-administered Romosozumab With Healthcare Provider-administered Romosozumab for Osteoporosis Phase 3
Completed NCT00545779 - BONCURE Study: A Study of Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis on Bisphosphonate Therapy. Phase 4
Active, not recruiting NCT01232647 - Vitamin K as Additive Treatment in Osteoporosis Phase 2/Phase 3
Completed NCT00666627 - Bisphosphonate Action on the Appendicular Skeleton: Evidence for Differential Effects Phase 2